Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s share price shot up 1.8% during trading on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The firm has a market capitalization of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The company has a debt-to-equity ratio of 0.52, a current ratio of 9.74 and a quick ratio of 9.41. The company’s 50-day moving average is C$0.58 and its 200-day moving average is C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- What Makes a Stock a Good Dividend Stock?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Insider Trades May Not Tell You What You Think
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
